Pharma's state-level pricing headache isn't going anywhere in 2018

Fierce Pharma --------- Members of Congress have railed on the pharma industry and its pricing for years, but alas no tangible proposals on the issue have gained steam. Instead, state governments are tackling pricing head on with new proposals around the country, and the industry is largely resisting. Already in Maryland, Nevada and California, lawmakers have passed bills challenging the drug pricing status quo in different ways. But that's just the start, according to PwC's Health Research Institute, as state lawmakers proposed 75 healthcare bills in 2017; 21 passed, according to the team. To learn more click on the picture below to read the article.